These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


291 related items for PubMed ID: 10453230

  • 41. Acute otitis media: part II. Treatment in an era of increasing antibiotic resistance.
    Pichichero ME.
    Am Fam Physician; 2000 Apr 15; 61(8):2410-6. PubMed ID: 10794582
    [Abstract] [Full Text] [Related]

  • 42. [Effective pharmacotherapy in endosurgical operations on the maxilla and ethmoidal labyrinth].
    Sedinkin AA.
    Vestn Otorinolaringol; 2004 Apr 15; (1):42-3. PubMed ID: 15134080
    [No Abstract] [Full Text] [Related]

  • 43. [Initial antibiotic therapy in acute otitis media and acute sinusitis in children].
    Garashchenko TI, Denisova OA, Kotov RV.
    Vestn Otorinolaringol; 2005 Apr 15; (3):62-3. PubMed ID: 16034353
    [No Abstract] [Full Text] [Related]

  • 44. [Usage of medicines inducing secretolisys in treatment of acute otitis media in children].
    Gotsadze K, Gogatishvili R.
    Georgian Med News; 2005 May 15; (122):21-5. PubMed ID: 15988076
    [Abstract] [Full Text] [Related]

  • 45. [Sultamicillin in treatment of acute middle ear infection in children].
    Kossowska E, Chmielik M, Komorowska A, Zaleski W.
    Pol Tyg Lek; 1993 Oct 15; 48 Suppl 2():9-10. PubMed ID: 8008666
    [No Abstract] [Full Text] [Related]

  • 46. Is acute otitis media a treatable disease?
    Klein JO.
    N Engl J Med; 2011 Jan 13; 364(2):168-9. PubMed ID: 21226583
    [No Abstract] [Full Text] [Related]

  • 47. [Treatment of acute otitis media in children. Some questions].
    del Castillo Martín F.
    Enferm Infecc Microbiol Clin; 1997 Apr 13; 15(4):212-7. PubMed ID: 9312281
    [No Abstract] [Full Text] [Related]

  • 48. Could one of the most widely prescribed antibiotics amoxicillin/clavulanate "augmentin" be a risk factor for autism?
    Fallon J.
    Med Hypotheses; 2005 Apr 13; 64(2):312-5. PubMed ID: 15607562
    [Abstract] [Full Text] [Related]

  • 49. Safety and tolerability of a new formulation (90 mg/kg/day divided every 12 h) of amoxicillin/clavulanate (Augmentin) in the empiric treatment of pediatric acute otitis media caused by drug-resistant Streptococcus pneumoniae.
    Bottenfield GW, Burch DJ, Hedrick JA, Schaten R, Rowinski CA, Davies JT.
    Pediatr Infect Dis J; 1998 Oct 13; 17(10):963-8. PubMed ID: 9802654
    [No Abstract] [Full Text] [Related]

  • 50. Occurrence of otitis media in children and assessment of treatment options.
    Nwokoye NN, Egwari LO, Olubi OO.
    J Laryngol Otol; 2015 Aug 13; 129(8):779-83. PubMed ID: 26072993
    [Abstract] [Full Text] [Related]

  • 51. Clarification of patient population in sinusitis article.
    Weinberg MG.
    Arch Intern Med; 2004 Mar 08; 164(5):568; author reply 570. PubMed ID: 15006836
    [No Abstract] [Full Text] [Related]

  • 52. A multicenter study on the clinical efficacy and safety of roxithromycin in the treatment of ear-nose-throat infections: comparison with amoxycillin/clavulanic acid.
    Mira E, Benazzo M.
    J Chemother; 2001 Dec 08; 13(6):621-7. PubMed ID: 11806623
    [Abstract] [Full Text] [Related]

  • 53. Moxifloxacin versus amoxicillin clavulanate in the treatment of acute maxillary sinusitis: a primary care experience.
    Rakkar S, Roberts K, Towe BF, Flores SM, Heyd A, Warner J.
    Int J Clin Pract; 2001 Jun 08; 55(5):309-15. PubMed ID: 11452678
    [Abstract] [Full Text] [Related]

  • 54. The variability and appropriateness of the antibiotic prescription of acute otitis media in childhood. The Spanish Study Group for Antibiotic Treatments.
    Solís G, Ochoa C, Pérez Méndez C.
    Int J Pediatr Otorhinolaryngol; 2000 Dec 22; 56(3):175-84. PubMed ID: 11137591
    [Abstract] [Full Text] [Related]

  • 55. [The analysis of adequacy of the treatment for acute otitis media and bacterial sinusitis in outpatient setting].
    Kriukov AI, Turovskiĭ AB, Balandin AV, Khamzalieva RB, Subbota DV.
    Vestn Otorinolaringol; 2006 Dec 22; (1):61-4. PubMed ID: 16482017
    [Abstract] [Full Text] [Related]

  • 56. [Pharmacoepidemiology of antibiotics in the treatment of respiratory tract infections in pediatric outpatients].
    Strachynskił LS, Bołko LM, Blokhin BM, Avdeeva TG, Tarasova GD, Egorova OA, Stroganov VP.
    Antibiot Khimioter; 1997 Dec 22; 42(10):10-4. PubMed ID: 9412396
    [No Abstract] [Full Text] [Related]

  • 57. [Antibiotic treatment of otitis media in children].
    de la Flor i Brú J.
    Aten Primaria; 1997 Sep 15; 20(4):205-7. PubMed ID: 9410145
    [No Abstract] [Full Text] [Related]

  • 58. Double-blind randomised trial of co-amoxiclav versus placebo for persistent otitis media with effusion in general practice.
    van Balen FA, de Melker RA, Touw-Otten FW.
    Lancet; 1996 Sep 14; 348(9029):713-6. PubMed ID: 8806290
    [Abstract] [Full Text] [Related]

  • 59. The clinical pharmacology of amoxicillin and clavulanic acid.
    Reed MD.
    Pediatr Infect Dis J; 1998 Oct 14; 17(10):957-62. PubMed ID: 9802653
    [No Abstract] [Full Text] [Related]

  • 60. Single-dose intramuscular ceftriaxone for acute otitis media in children.
    Eur J Pediatr; 1993 Jun 14; 152(6):535. PubMed ID: 8335025
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.